Intra-arterial administration of NEP inhibitors (candoxatril or thiorphan) produced vasoconstriction in patients with hypertension, but that effect was alleviated by co-administration of an endothelin 1 receptor blocker [67]. The gene discussed is EDNRA; the disease is hypertensive disorder.